Stephen Basil Thomas

Director

Stephen Basil Thomas (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Climb Bio, Inc. (CLYM). The largest single filing was $1.4M of CLYM (100,000 sh × $13.67, as filed), executed Sep 15.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.2M

shares × price, as filed

Last traded

Sep 15

Filed Sep 17

Median ADV $22.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

CLYM

Climb Bio, Inc. CLYM · 0 buys · 3 sells 3 filings

Recent filings

CLYMSALE Climb Bio, Inc. View filing → $1.4M
100,000 sh × $13.67
Exec Sep 15
Filed Sep 17 · 4:15 PM ET CLYMSALE Climb Bio, Inc. View filing → $350K
50,000 sh across 2 lots
Exec Feb 25
Filed Feb 27 · 5:30 PM ET CLYMSALE Climb Bio, Inc. View filing → $471K
90,000 sh × $5.23
Exec Feb 12
Filed Feb 17 · 5:30 PM ET